NFE2L2 and non-small cell lung carcinoma: Another recent study found that higher expression of nuclear factor erythroid 2-related factor 2 (NRF2)-regulated metabolic gene signature (NRMGS) predicted poor overall survival in eight independent NSCLC cohorts [9].